GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicell Inc (MEX:OMCL) » Definitions » Cyclically Adjusted Price-to-FCF

Omnicell (MEX:OMCL) Cyclically Adjusted Price-to-FCF : 3.33 (As of Sep. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Omnicell Cyclically Adjusted Price-to-FCF?

As of today (2024-09-25), Omnicell's current share price is MXN886.00. Omnicell's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 was MXN266.40. Omnicell's Cyclically Adjusted Price-to-FCF for today is 3.33.

The historical rank and industry rank for Omnicell's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MEX:OMCL' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 13.83   Med: 66.74   Max: 129.04
Current: 22.94

During the past years, Omnicell's highest Cyclically Adjusted Price-to-FCF was 129.04. The lowest was 13.83. And the median was 66.74.

MEX:OMCL's Cyclically Adjusted Price-to-FCF is ranked worse than
52.2% of 182 companies
in the Healthcare Providers & Services industry
Industry Median: 21.01 vs MEX:OMCL: 22.94

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Omnicell's adjusted free cash flow per share data for the three months ended in Jun. 2024 was MXN17.968. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is MXN266.40 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Omnicell Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Omnicell's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicell Cyclically Adjusted Price-to-FCF Chart

Omnicell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.77 109.96 122.37 32.74 21.60

Omnicell Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.27 26.20 21.60 15.61 14.09

Competitive Comparison of Omnicell's Cyclically Adjusted Price-to-FCF

For the Health Information Services subindustry, Omnicell's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicell's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Omnicell's Cyclically Adjusted Price-to-FCF falls into.



Omnicell Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Omnicell's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=886.00/266.4
=3.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omnicell's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Omnicell's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=17.968/132.5538*132.5538
=17.968

Current CPI (Jun. 2024) = 132.5538.

Omnicell Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 1.318 100.428 1.740
201412 10.692 99.070 14.306
201503 2.976 99.621 3.960
201506 -3.022 100.684 -3.979
201509 -4.615 100.392 -6.094
201512 13.430 99.792 17.839
201603 6.551 100.470 8.643
201606 -5.406 101.688 -7.047
201609 0.554 101.861 0.721
201612 9.152 101.863 11.909
201703 10.909 102.862 14.058
201706 1.968 103.349 2.524
201709 -11.423 104.136 -14.540
201712 -3.057 104.011 -3.896
201803 1.976 105.290 2.488
201806 4.094 106.317 5.104
201809 1.095 106.507 1.363
201812 16.337 105.998 20.430
201903 4.496 107.251 5.557
201906 5.372 108.070 6.589
201909 19.084 108.329 23.352
201912 8.658 108.420 10.585
202003 6.158 108.902 7.495
202006 15.186 108.767 18.507
202009 13.513 109.815 16.311
202012 29.263 109.897 35.296
202103 19.522 111.754 23.155
202106 24.688 114.631 28.548
202109 11.671 115.734 13.367
202112 17.711 117.630 19.958
202203 -13.021 121.301 -14.229
202206 -9.503 125.017 -10.076
202209 2.330 125.227 2.466
202212 28.329 125.222 29.988
202303 -0.349 127.348 -0.363
202306 21.900 128.729 22.551
202309 16.359 129.860 16.698
202312 9.716 129.419 9.951
202403 13.650 131.776 13.731
202406 17.968 132.554 17.968

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Omnicell  (MEX:OMCL) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Omnicell Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Omnicell's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicell Business Description

Traded in Other Exchanges
Address
2625 Augustine Drive, Suite 301, Santa Clara, CA, USA, 95054
Omnicell Inc provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.